As Dow seeks growth, new Enlist crop/chemicals seen as key

Mon Mar 10, 2014 8:12am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

By Carey Gillam

INDIANAPOLIS (Reuters) - Dan Kittle has spent more than a decade waiting for this day.

As the man in charge of research and development at Dow AgroSciences, the unit of Dow Chemical Co (DOW.N: Quote) that develops agricultural seeds and pesticides, Kittle remembers the "big shock" when rival Monsanto Co (MON.N: Quote) unveiled a genetically modified seed in 1996 designed to be used in combination with a specific herbicide, a combination that rapidly led Monsanto to riches.

Since then, Monsanto has become the world's largest seed company with $15 billion in annual sales, up roughly 200 percent from a decade ago, and Kittle and a team of Dow researchers have been working to catch up.

In that quest, Dow has increased research and development spending 75 percent, expanded greenhouse space, also by 75 percent, and made 14 acquisitions since 2007.

With a string of new crop and chemical products in its pipeline, the company projects it will double revenues over the next five to seven years. For 2013, sales totaled $7.1 billion.

One key to Dow's rise in the agriculture seed and chemical kingdom is the company's new GMO seed and herbicide combination branded the "Enlist Weed Control System." U.S. regulators have indicated they are poised to grant needed approvals, and after more than two years of scrutiny, the U.S. Department of Agriculture's final public comment period closes on Tuesday.

"Enlist is the most important release we've had," said Kittle.

Dow pegs the market opportunity for Enlist at about $1 billion. It plans to offer Enlist corn and soybean, the two most widely planted U.S. crops, next year in concert with Dow's Enlist Duo herbicide, which the crops are engineered to tolerate.   Continued...

A tractor is silhouetted on a hillside in Prairie City, Iowa, November 16, 2007. REUTERS/Shannon Stapleton